CNS pipeline · person
Ingrid Delaet, PhD
Chief Regulatory Officer of Neurocrine Biosciences since October 2022, leading regulatory affairs, quality assurance, and medical writing. She has more than 25 years of drug development experience and previously served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals.
- 1 company
Courtesy Neurocrine Biosciences
Current roles
- Neurocrine Biosciences, Inc.Chief Regulatory Officer · Executive
Appears with
People sharing a company with Ingrid.
- Andrew Ratz · Neurocrine Biosciences, Inc.
- Christine A. Poon · Neurocrine Biosciences, Inc.
- Darin M. Lippoldt · Neurocrine Biosciences, Inc.
- David W. Boyer · Neurocrine Biosciences, Inc.
- Eric Benevich · Neurocrine Biosciences, Inc.
- Gary A. Lyons · Neurocrine Biosciences, Inc.
- George J. Morrow · Neurocrine Biosciences, Inc.
- Johanna Mercier · Neurocrine Biosciences, Inc.
- Jude Onyia · Neurocrine Biosciences, Inc.
- Julie S. Cooke · Neurocrine Biosciences, Inc.
- Kevin C. Gorman · Neurocrine Biosciences, Inc.
- Kyle W. Gano · Neurocrine Biosciences, Inc.
- Leslie V. Norwalk · Neurocrine Biosciences, Inc.
- Matthew C. Abernethy · Neurocrine Biosciences, Inc.
- Richard F. Pops · Neurocrine Biosciences, Inc.
- Sanjay Keswani · Neurocrine Biosciences, Inc.
- Shalini Sharp · Neurocrine Biosciences, Inc.
- Stephen A. Sherwin · Neurocrine Biosciences, Inc.
- William H. Rastetter · Neurocrine Biosciences, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.